Selected research
Industry Research
Alfentanil Industry Research Report 2026
Market perspective
The global Alfentanil market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Alfentanil is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Alfentanil is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Alfentanil is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Alfentanil include Johnson & Johnson, Novartis, Pfizer, Max Health, JV Healthcare, Horizon Hospital Healthcare, Hameln Pharmaceuticals, CristÁLia and Auden Mckenzie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Alfentanil market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Alfentanil Market by Company
Johnson & Johnson
Novartis
Pfizer
Max Health
JV Healthcare
Horizon Hospital Healthcare
Hameln Pharmaceuticals
CristÁLia
Auden Mckenzie
Angelini Pharma
Algol Pharma
Akorn
Alfentanil Segment by Type
Intravenous
Subcutaneous
Alfentanil Segment by Application
Perioperative Analgesia
Adjunct to General Anesthesia
Alfentanil Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alfentanil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Alfentanil and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alfentanil.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Alfentanil manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Alfentanil by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Alfentanil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Intravenous
- Subcutaneous
Applications
- Perioperative Analgesia
- Adjunct to General Anesthesia
Companies covered
- Johnson & Johnson
- Novartis
- Pfizer
- Max Health
- JV Healthcare
- Horizon Hospital Healthcare
- Hameln Pharmaceuticals
- CristÁLia
- Auden Mckenzie
- Angelini Pharma
- Algol Pharma
- Akorn
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Alfentanil Market Size (2021-2032)
- 2.2.2 Global Alfentanil Sales (2021-2032)
- 2.2.3 Global Alfentanil Market Average Price (2021-2032)
- 2.3 Alfentanil by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Intravenous
- 2.3.3 Subcutaneous
- 2.4 Alfentanil by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Perioperative Analgesia
- 2.4.3 Adjunct to General Anesthesia
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Alfentanil Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Alfentanil Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Alfentanil Revenue of Manufacturers (2021-2026)
- 3.4 Global Alfentanil Average Price by Manufacturers (2021-2026)
- 3.5 Global Alfentanil Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Alfentanil, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Alfentanil, Product Type & Application
- 3.8 Global Manufacturers of Alfentanil, Established Date
- 3.9 Global Alfentanil Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Johnson & Johnson
- 4.1.1 Johnson & Johnson Company Information
- 4.1.2 Johnson & Johnson Business Overview
- 4.1.3 Johnson & Johnson Alfentanil Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Johnson & Johnson Alfentanil Product Portfolio
- 4.1.5 Johnson & Johnson Recent Developments
- 4.2 Novartis
- 4.2.1 Novartis Company Information
- 4.2.2 Novartis Business Overview
- 4.2.3 Novartis Alfentanil Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Alfentanil Product Portfolio
- 4.2.5 Novartis Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Alfentanil Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Alfentanil Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 Max Health
- 4.4.1 Max Health Company Information
- 4.4.2 Max Health Business Overview
- 4.4.3 Max Health Alfentanil Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Max Health Alfentanil Product Portfolio
- 4.4.5 Max Health Recent Developments
- 4.5 JV Healthcare
- 4.5.1 JV Healthcare Company Information
- 4.5.2 JV Healthcare Business Overview
- 4.5.3 JV Healthcare Alfentanil Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 JV Healthcare Alfentanil Product Portfolio
- 4.5.5 JV Healthcare Recent Developments
- 4.6 Horizon Hospital Healthcare
- 4.6.1 Horizon Hospital Healthcare Company Information
- 4.6.2 Horizon Hospital Healthcare Business Overview
- 4.6.3 Horizon Hospital Healthcare Alfentanil Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Horizon Hospital Healthcare Alfentanil Product Portfolio
- 4.6.5 Horizon Hospital Healthcare Recent Developments
- 4.7 Hameln Pharmaceuticals
- 4.7.1 Hameln Pharmaceuticals Company Information
- 4.7.2 Hameln Pharmaceuticals Business Overview
- 4.7.3 Hameln Pharmaceuticals Alfentanil Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hameln Pharmaceuticals Alfentanil Product Portfolio
- 4.7.5 Hameln Pharmaceuticals Recent Developments
- 4.8 CristÁLia
- 4.8.1 CristÁLia Company Information
- 4.8.2 CristÁLia Business Overview
- 4.8.3 CristÁLia Alfentanil Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 CristÁLia Alfentanil Product Portfolio
- 4.8.5 CristÁLia Recent Developments
- 4.9 Auden Mckenzie
- 4.9.1 Auden Mckenzie Company Information
- 4.9.2 Auden Mckenzie Business Overview
- 4.9.3 Auden Mckenzie Alfentanil Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Auden Mckenzie Alfentanil Product Portfolio
- 4.9.5 Auden Mckenzie Recent Developments
- 4.10 Angelini Pharma
- 4.10.1 Angelini Pharma Company Information
- 4.10.2 Angelini Pharma Business Overview
- 4.10.3 Angelini Pharma Alfentanil Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Angelini Pharma Alfentanil Product Portfolio
- 4.10.5 Angelini Pharma Recent Developments
- 4.11 Algol Pharma
- 4.11.1 Algol Pharma Company Information
- 4.11.2 Algol Pharma Business Overview
- 4.11.3 Algol Pharma Alfentanil Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Algol Pharma Alfentanil Product Portfolio
- 4.11.5 Algol Pharma Recent Developments
- 4.12 Akorn
- 4.12.1 Akorn Company Information
- 4.12.2 Akorn Business Overview
- 4.12.3 Akorn Alfentanil Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Akorn Alfentanil Product Portfolio
- 4.12.5 Akorn Recent Developments
5 Global Alfentanil Market Scenario by Region
- 5.1 Global Alfentanil Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Alfentanil Sales by Region: 2021-2032
- 5.2.1 Global Alfentanil Sales by Region: 2021-2026
- 5.2.2 Global Alfentanil Sales by Region: 2027-2032
- 5.3 Global Alfentanil Revenue by Region: 2021-2032
- 5.3.1 Global Alfentanil Revenue by Region: 2021-2026
- 5.3.2 Global Alfentanil Revenue by Region: 2027-2032
- 5.4 North America Alfentanil Market Facts & Figures by Country
- 5.4.1 North America Alfentanil Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Alfentanil Sales by Country (2021-2032)
- 5.4.3 North America Alfentanil Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Alfentanil Market Facts & Figures by Country
- 5.5.1 Europe Alfentanil Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Alfentanil Sales by Country (2021-2032)
- 5.5.3 Europe Alfentanil Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Alfentanil Market Facts & Figures by Country
- 5.6.1 Asia Pacific Alfentanil Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Alfentanil Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Alfentanil Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Alfentanil Market Facts & Figures by Country
- 5.7.1 South America Alfentanil Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Alfentanil Sales by Country (2021-2032)
- 5.7.3 South America Alfentanil Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Alfentanil Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Alfentanil Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Alfentanil Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Alfentanil Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Alfentanil Sales by Type (2021-2032)
- 6.1.1 Global Alfentanil Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Alfentanil Sales Market Share by Type (2021-2032)
- 6.2 Global Alfentanil Revenue by Type (2021-2032)
- 6.2.1 Global Alfentanil Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Alfentanil Revenue Market Share by Type (2021-2032)
- 6.3 Global Alfentanil Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Alfentanil Sales by Application (2021-2032)
- 7.1.1 Global Alfentanil Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Alfentanil Sales Market Share by Application (2021-2032)
- 7.2 Global Alfentanil Revenue by Application (2021-2032)
- 7.2.1 Global Alfentanil Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Alfentanil Revenue Market Share by Application (2021-2032)
- 7.3 Global Alfentanil Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Alfentanil Value Chain Analysis
- 8.1.1 Alfentanil Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Alfentanil Production Mode & Process
- 8.2 Alfentanil Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Alfentanil Distributors
- 8.2.3 Alfentanil Customers
9 Global Alfentanil Analyzing Market Dynamics
- 9.1 Alfentanil Industry Trends
- 9.2 Alfentanil Industry Drivers
- 9.3 Alfentanil Industry Opportunities and Challenges
- 9.4 Alfentanil Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst